Research
Hormonal
GLP-1 receptor agonists (GLP-1 RAs) have shown promising potential in promoting weight loss and preventing diseases associated with obesity.
GLP-1 RAs may be considered as a pharmacologic option for obesity treatment.
StrongSupportsmedium confidence
Researchers are particularly interested in 1 type of drug, glucagon-like peptide 1 receptor agonists (GLP-1 RAs), because of its promising potential in addressing the limitations of non-pharmacologic treatments.
Why this rating
The review discusses the effectiveness of GLP-1 RAs based on existing research.
Source
Effect of GLP-1 receptor agonists on weight and cardiovascular outcomes: A review
Fatima Ali Raza et al. · Medicine · 2024
reviewCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →